Get Premium to unlock powerful stock data

Rhenman & Partners Asset Management AB Buys Johnson & Johnson, Pfizer Inc, Biogen Inc, Sells Acceleron Pharma Inc, Inovalon Holdings Inc, Regeneron Pharmaceuticals Inc

Author's Avatar
insider
Nov 12, 2021
Article's Main Image
Stockholm, V7, based Investment company Rhenman & Partners Asset Management AB (Current Portfolio) buys Johnson & Johnson, Pfizer Inc, Biogen Inc, McKesson Corp, Anthem Inc, sells Acceleron Pharma Inc, Inovalon Holdings Inc, Regeneron Pharmaceuticals Inc, NovoCure, Vertex Pharmaceuticals Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Rhenman & Partners Asset Management AB. As of 2021Q3, Rhenman & Partners Asset Management AB owns 92 stocks with a total value of $1.4 billion. These are the details of the buys and sells.

For the details of Rhenman & Partners Asset Management AB's stock buys and sells, go to https://www.gurufocus.com/guru/rhenman+%26+partners+asset+management+ab/current-portfolio/portfolio

These are the top 5 holdings of Rhenman & Partners Asset Management AB
  1. Horizon Therapeutics PLC (HZNP) - 470,000 shares, 3.61% of the total portfolio. Shares reduced by 10.48%
  2. UnitedHealth Group Inc (UNH) - 125,000 shares, 3.43% of the total portfolio.
  3. Anthem Inc (ANTM) - 120,000 shares, 3.14% of the total portfolio. Shares added by 26.32%
  4. Johnson & Johnson (JNJ) - 270,000 shares, 3.06% of the total portfolio. Shares added by 260.00%
  5. Pfizer Inc (PFE) - 1,000,000 shares, 3.02% of the total portfolio. Shares added by 100.00%
New Purchase: IVERIC bio Inc (ISEE)

Rhenman & Partners Asset Management AB initiated holding in IVERIC bio Inc. The purchase prices were between $7.07 and $17.5, with an estimated average price of $10.82. The stock is now traded at around $17.320000. The impact to a portfolio due to this purchase was 0.4%. The holding were 350,000 shares as of 2021-09-30.

New Purchase: Privia Health Group Inc (PRVA)

Rhenman & Partners Asset Management AB initiated holding in Privia Health Group Inc. The purchase prices were between $23.56 and $46.78, with an estimated average price of $35.02. The stock is now traded at around $32.270000. The impact to a portfolio due to this purchase was 0.4%. The holding were 240,000 shares as of 2021-09-30.

New Purchase: Olink Holding AB (OLK)

Rhenman & Partners Asset Management AB initiated holding in Olink Holding AB. The purchase prices were between $23.42 and $37.93, with an estimated average price of $31.5. The stock is now traded at around $24.200000. The impact to a portfolio due to this purchase was 0.24%. The holding were 140,000 shares as of 2021-09-30.

Added: Johnson & Johnson (JNJ)

Rhenman & Partners Asset Management AB added to a holding in Johnson & Johnson by 260.00%. The purchase prices were between $161.5 and $179.47, with an estimated average price of $170.65. The stock is now traded at around $165.530000. The impact to a portfolio due to this purchase was 2.21%. The holding were 270,000 shares as of 2021-09-30.

Added: Pfizer Inc (PFE)

Rhenman & Partners Asset Management AB added to a holding in Pfizer Inc by 100.00%. The purchase prices were between $39.25 and $50.42, with an estimated average price of $44.27. The stock is now traded at around $49.675500. The impact to a portfolio due to this purchase was 1.51%. The holding were 1,000,000 shares as of 2021-09-30.

Added: Biogen Inc (BIIB)

Rhenman & Partners Asset Management AB added to a holding in Biogen Inc by 66.67%. The purchase prices were between $282.99 and $369.05, with an estimated average price of $328.16. The stock is now traded at around $267.980000. The impact to a portfolio due to this purchase was 1.19%. The holding were 150,000 shares as of 2021-09-30.

Added: McKesson Corp (MCK)

Rhenman & Partners Asset Management AB added to a holding in McKesson Corp by 89.74%. The purchase prices were between $188.42 and $208.66, with an estimated average price of $199.89. The stock is now traded at around $223.315000. The impact to a portfolio due to this purchase was 0.98%. The holding were 148,000 shares as of 2021-09-30.

Added: Anthem Inc (ANTM)

Rhenman & Partners Asset Management AB added to a holding in Anthem Inc by 26.32%. The purchase prices were between $357.51 and $398.13, with an estimated average price of $380.13. The stock is now traded at around $435.140000. The impact to a portfolio due to this purchase was 0.65%. The holding were 120,000 shares as of 2021-09-30.

Added: Apellis Pharmaceuticals Inc (APLS)

Rhenman & Partners Asset Management AB added to a holding in Apellis Pharmaceuticals Inc by 84.02%. The purchase prices were between $31.4 and $69.84, with an estimated average price of $56.51. The stock is now traded at around $41.500000. The impact to a portfolio due to this purchase was 0.59%. The holding were 561,269 shares as of 2021-09-30.

Sold Out: Inovalon Holdings Inc (INOV)

Rhenman & Partners Asset Management AB sold out a holding in Inovalon Holdings Inc. The sale prices were between $31.94 and $40.85, with an estimated average price of $37.78.

Sold Out: Regeneron Pharmaceuticals Inc (REGN)

Rhenman & Partners Asset Management AB sold out a holding in Regeneron Pharmaceuticals Inc. The sale prices were between $574.03 and $680.96, with an estimated average price of $621.14.

Sold Out: Baxter International Inc (BAX)

Rhenman & Partners Asset Management AB sold out a holding in Baxter International Inc. The sale prices were between $73.77 and $83.61, with an estimated average price of $79.12.

Sold Out: Zai Lab Ltd (ZLAB)

Rhenman & Partners Asset Management AB sold out a holding in Zai Lab Ltd. The sale prices were between $105 and $178.37, with an estimated average price of $144.08.

Sold Out: LivaNova PLC (LIVN)

Rhenman & Partners Asset Management AB sold out a holding in LivaNova PLC. The sale prices were between $76.02 and $88.62, with an estimated average price of $82.24.



Here is the complete portfolio of Rhenman & Partners Asset Management AB. Also check out:

1. Rhenman & Partners Asset Management AB's Undervalued Stocks
2. Rhenman & Partners Asset Management AB's Top Growth Companies, and
3. Rhenman & Partners Asset Management AB's High Yield stocks
4. Stocks that Rhenman & Partners Asset Management AB keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus